Lexicon Pharmaceuticals | LXRX - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
Abbott USD 297M 2M 2026-09
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Akebia Therapeutics 342.13M 7.53M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
AstraZeneca USD 371M 31M 2026-09
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Coherus Biosciences USD 2.25M 76K 2025-12
Eli Lilly USD 316M 201.3M 2026-09
Halozyme Therapeutics USD 6.04M 457K 2026-09
Illumina USD 24M 0 2026-09
Insmed USD 20.41M 1.57M 2026-09
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
J&J USD 43M 25M 2026-03
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
MacroGenics USD 4.4M 493K 2026-06
MannKind USD 10.58M 4.24M 2026-09
Merck USD 525M 46M 2026-06
Moderna USD 10.96B 527M 2026-06
Novartis USD 468M 6M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 3.37M 11K 2024-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Thermo Fisher Scientific USD 417M 63M 2026-09
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
United Therapeutics USD 2.9M 0 2026-09
Vanda Pharmaceuticals -1.37B 1.97B 2025-12